Galectin Therapeutics
GALT
#9131
Rank
HK$0.64 B
Marketcap
HK$10.24
Share price
-7.04%
Change (1 day)
-62.63%
Change (1 year)

Revenue for Galectin Therapeutics (GALT)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Galectin Therapeutics from 2009 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HK$0.29 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
HK$2.21 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA